Corpus ID: 197637410

Neurological Involvement in Rheumatoid Arthritis

  title={Neurological Involvement in Rheumatoid Arthritis},
  author={Safaa Mahran},
Rheumatoid Arthritis (RA) is a chronic autoimmune disease of unknown aetiology. It is famous of affecting the synovial joints leading to its inflammation and deformity specially the small joints of the hands and feet. However other extra-articular manifestations do exist including nervous system affection. Neurological affection in RA can be divided into central nervous system, peripheral nervous system and iatrogenic neuropathy which can cause central and/or peripheral nervous manifestations 

Figures from this paper


Peripheral neuropathies of the forearm and hand in rheumatoid arthritis: diagnosis and options for treatment
Clinical outcomes of peripheral neuropathies of the upper extremity associated with rheumatoid arthritis are reviewed and the proper diagnosis and operative indication are discussed. Expand
A case of rheumatoid nodule formation within the central nervous system and review of the literature.
It is concluded that CNS nodules are a rare extraarticular feature of RA which, although often of uncertain clinical significance, should be considered as a possible etiology when neurologic dysfunction occurs in the RA patient. Expand
An unusual presentation of rheumatoid meningitis.
The possibility of central nervous system involvement by rheumatoid arthritis should be considered in patients with a history of rhearatoid arthritis even in the absence of systemic symptoms. Expand
Vasculitic neuropathy: profile of twenty patients.
Though vasculitic neuropathy is classically associated with Collagen vascular syndromes like, polyarteritis nodosa, rheumatoid arthritis and systemic lupus erythematosis, only 13/20 of patients had definitiveCollagen vascular disease. Expand
Cerebral vasculitis in a patient with rheumatoid arthritis.
A case of cerebral vasculitis is reported in a 59-year-old woman with a 20-year history of destructive rheumatoid factor-positive RA that was well controlled by methotrexate and there was no evidence of a relapse at last follow-up after 5 months. Expand
Peripheral neuropathies in rheumatic disease—a guide to diagnosis
Although available treatment options have greatly reduced the risk of patients with inflammatory disorders developing systemic complications, among which includes peripheral neuropathy, new therapeutic agents can trigger toxic or immune-mediated neuropathies and treatment will need to be adjusted accordingly. Expand
The electroneurophysiological findings in rheumatoid arthritis patients.
The results confirm earlier observations that symptoms of neuropathy are fairly common in cases of RA without there being any clear correlation with any clinical variable and SEPs should also be used for the evaluation of subclinical myelopathy due to atlantoaxial subluxation or vasculitis. Expand
Systemic rheumatoid vasculitis: a review.
Although RV has apparently been decreasing over the last 2 decades, possibly as a consequence of the more energetic approach to the management of RA currently used, it remains an important complication of RA that needs to be promptly recognized and treated. Expand
Subclinical peripheral nerve involvement in patients with rheumatoid arthritis.
Patients with RA may have electrophysiologic and histologic findings of peripheral nerve damage, even in the absence of clinical evidence of peripheral nerves involvement. Expand
Prevalence of peripheral neuropathy in patients with newly diagnosed rheumatoid arthritis
This study shows high prevalence of subclinical neuropathy in Indian patients with RA, which may be an important contributor to disability. Expand